16 November 2022 in IEEE Transactions on Medical Imaging
Optical Coherence Tomography Angiography (OCTA), a functional extension of OCT, has the potential to replace most invasive fluorescein angiography (FA) exams in ophthalmology. So far, OCTA’s field of view is however still lacking behind fluorescence fundus photography techniques. This is problematic, because many retinal diseases manifest at an early stage by changes of the peripheral retinal capillary network. It is therefore desirable to expand OCTA’s field of view to match that of ultra-widefield fundus cameras. We present a custom developed clinical high-speed swept-source OCT (SS-OCT) system operating at an acquisition rate 8-16 times faster than today’s state-of-the-art commercially available OCTA devices. Its speed allows us to capture ultra-wide fields of view of up to 90 degrees with an unprecedented sampling density and hence extraordinary resolution by merging two single shot scans with 60 degrees in diameter. To further enhance the visual appearance of the angiograms, we developed for the first time a three-dimensional deep learning based algorithm for denoising volumetric OCTA data sets. We showcase its imaging performance and clinical usability by presenting images of patients suffering from diabetic retinopathy.
28 July 2023 in Ophthalmology Retina
To evaluate the association of microvascular lesions on ultra-widefield (UWF) color-fundus (CF) images with retinal nonperfusion (RNP) up to the midperiphery on single-capture widefield (WF) optical coherence tomography angiography (OCTA) in patients with diabetic retinopathy (DR). Cross-sectional study. Seventy-five eyes of 50 patients with mild to severe non-proliferative DR (NPDR) and proliferative DR (PDR) were included in this analysis. DR stage (Early Treatment Diabetic Retinopathy Study; ETDRS) and presence of predominantly peripheral lesions (PPL) were assessed on UWF-CF images acquired with a Zeiss Clarus 700. Single-capture 65°-WF-OCTA was performed using a PlexElite prototype (Carl Zeiss Meditec Inc.). A custom grid consisting of a central ETDRS grid extended by two rings reaching up to the midperiphery was overlaid to subdivide retinal areas visible on WF-OCTA en-face images. RNP was measured in each area and in total. Nonperfusion index (NPI) was calculated from total RNP. On UWF-CF images the number of microaneurysms, hemorrhages, neovascularizations, and areas with intraretinal microvascular abnormalities (IRMAs) were evaluated using the same grid. Association of diabetic lesions with RNP was calculated using Spearman correlations (rs). Median RNP on WF-OCTA was 0mm2 (0-0.9), 4.9mm2 (1.9-5.4), 23.4mm2 (17.8-37), and 68.4mm2 (40.8-91.7) in mild, moderate, severe NPDR and PDR, respectively. We found a statistically significant correlation (p<0.01) of overall RNP (rs=0.96,) and NPI (rs=0.97) on WF-OCTA with ETDRS level. Number of grid-fields affected by IRMAs on CF images was highly associated with NPI (rs=0.86, p<0.01). IRMAs and RNPs had similar topographic distributions with high correlations in affected areas. Eyes with PPL (n=43 eyes, 57%) on CF-images had a significantly higher NPI (p=0.014) than eyes without PPL. The combination of UWF-CF imaging and single-capture WF-OCTA allows precise and non-invasive analysis of the retinal vasculature up to the midperiphery in patients with DR. The presence and extent of IRMAs on CF images may serve as an indicator for underlying RNP, which is more pronounced in eyes with PPL.
21 August 2020 in Neurophotonics
Alzheimer’s disease (AD) is the most common form of dementia worldwide. In 2019, 5.8 million people in the United States were suffering from AD. The numbers are increasing in our aging society, and there is still no cure available.1 Our society is facing a considerable social and financial burden due to severe cognitive impairment of affected patients. Ultimately, they are dependent on care-giving.1 On a cellular level, AD is characterized by the degeneration of neurons and the formation of intracellular neurofibrillary tangles composed of tau protein and extracellular plaques composed of amyloid-beta () protein.2,3 The definite diagnosis of the disease can only be done postmortem by histologic analyses of different regions of the cerebral cortex. Using different immunohistochemical and molecular methods, the presence of plaques and tau protein tangles has to be confirmed.4 plaques are in the range of 10 to in diameter and have been investigated using light and fluorescence microscopy as well as Raman spectroscopy.2,3,5 – 8 For these imaging techniques, processing steps such as sectioning and molecular labeling of the tissue are required. Further research is urgently needed to fully understand the complex underlying mechanisms involved in AD and the formation of these plaques using a label-free, tissue preserving, and volumetric technique.9
28 August 2024 in Canadian Journal of Ophthalmology
To investigate the localization, distribution, and type of central microaneurysms (MAs) and their relationship with retinal vascular alterations in patients with retinal vein occlusion (RVO). In this cross-sectional study, ultra-widefield color fundus photography (UWF-CF), standard and single-capture 65° widefield (WF) optical coherence tomography angiography (OCTA) were performed in consecutive patients with RVO treated at the Department of Ophthalmology and Optometry, Medical University of Vienna. UWF-CF, en face and B-Scans in 6 mm × 6 mm OCTA were examined for detection of MAs. Nonperfusion areas (NPA) and collateral vessels (CV) were evaluated on WF-OCTA, ghost vessels (GV), and tortuous vessels (TV) on UWF-CF. One-hundred-and-twelve patients were included in the study, and data from 59 eyes of 59 patients with disease duration longer than 3 months, good image quality, and without relevant ocular comorbidities were eligible for statistical analysis. Fifty-six of 59 (94.9%) patients were previously treated with anti-vascular endothelial growth factor agents for macular edema, 31 of 59 (52.5%) patients presented with MAs in the central 6 mm and 60 MAs were found in total using multimodal imaging. There was no statistically significant difference in the greatest diameter of fluid-associated versus non-fluid-associated MAs (p = 0.53). Eyes with MAs were associated with CV, TV, and GV (χ2-test; p < 0.001, p = 0.0498, and p = 0.001). Median NPA was 27.3 mm2 (quartiles 1.3-62.8 mm2) in eyes with MAs and 0 mm2 (quartiles 0-36.2 mm2) in eyes without MAs (Mann-Whitney-U-test; p = 0.018). MAs were associated with extensive NPA, the presence of CV, GV, and TV. There was no correlation between the diameter of the MA and the adjacent intraretinal fluid in our predominantly pretreated RVO study patients.